ArticleAmerican journal of public health2022
Associated Costs Are a Barrier to HIV Preexposure Prophylaxis Access in the United States.
Abstract readEditorial
In one paragraph
Article in American journal of public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Potential Risks and Benefits of Low-barrier Access and Monitoring for HIV Pre-exposure Prophylaxis: A Modeling Study.The Journal of infectious diseases · 2026Article
- Applying Behavioral Economics to HIV Prevention: Development of a Novel PrEP Demand Task.AIDS and behavior · 2026Article
- Characteristics of US Counties with Low Pre-exposure Prophylaxis (PrEP) Use and Limited Access to PrEP Prescribing Clinics.AIDS and behavior · 2026Article
- HIV Pre-Exposure Prophylaxis Use Among South Asian Sexual Minority Men in the United States: Pilot Web-Based Survey Study.JMIR formative research · 2026Article
- Where you live matters, but action is personal: insights from multilevel analysis of pre-exposure prophylaxis awareness, willingness, and use among men who have sex with men in China.Infectious diseases of poverty · 2026Article
- Pre-Exposure prophylaxis knowledge, use and adherence among a US national sample of women.AIDS care · 2026Article
- Policy Recommendations to Support Equitable Access to Long-Acting Injectables for HIV Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Article
- "One less thing to worry about": Barriers and facilitators of PrEP uptake among MSM in Karachi, Pakistan: A qualitative study.PLOS global public health · 2026Article
- Article
- Using Structural Equation Modeling to Examine Barriers and Facilitators of HIV Pre-Exposure Prophylaxis Willingness and Length of Use in Men Who Have Sex with Men Who Use Substances in Eight Southern US Cities.AIDS patient care and STDs · 2025Article
- Preferences for HIV preexposure prophylaxis care among gay, bisexual, and other MSM: a large discrete choice experiment.AIDS (London, England) · 2025Article
- Oral pre-exposure prophylaxis (PrEP) receipt and persistence among opioid-dependent people who inject drugs initiating PrEP for HIV prevention.Journal of substance use and addiction treatment · 2025Article
- PrEP Navigator Perceptions of the Implementation of Injectable PrEP on HIV Prevention in Tennessee.International journal of environmental research and public health · 2025Article
- Multilevel Intervention to Support Tailored and Responsive HIV Pre-Exposure Prophylaxis Care in Rural North Carolina: Protocol for a Randomized Controlled Trial.JMIR research protocols · 2025Article
- Blending De-implementation and Implementation to Promote Adoption of Universal PrEP Guidelines: Determinants, Strategies, and Outcomes.Critical public health · 2025Article
- Clustering affordable care act qualified health plans to understand how and where insurance facilitates or impedes access to HIV prevention.AIDS research and therapy · 2024Article
- Perceived Versus Actual Costs of HIV Pre-Exposure Prophylaxis Among Gay, Bisexual, and Other Men Who Have Sex with Men in the United States.AIDS patient care and STDs · 2024Article
- Leveling Up PrEP: Implementation Strategies at System and Structural Levels to Expand PrEP Use in the United States.Current HIV/AIDS reports · 2024Review
- HIV Pre-exposure Prophylaxis (PrEP) Care in Belgium: A mixed-methods Study on PrEP Users' Experiences and Service Delivery Preferences.AIDS and behavior · 2024Article
- A Community-Based Pre-Exposure Prophylaxis Telehealth Program Focused on Latinx Sexual Minority Men.AIDS patient care and STDs · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Karishma SrikanthAt the time of this study, Karishma Srikanth was with the Batten School of Leadership and Public Policy, University of Virginia, Charlottesville. Edwin Corbin Gutierrez and Tim Horn were with the National Alliance of State & Territorial AIDS Directors (NASTAD), Washington, DC. Amy Killelea was with NASTAD and Killelea Consulting, Arlington, Virginia. Andrew Strumpf and Kathleen A. McManus are with the Division of Infectious Diseases and International Health, University of Virginia, Charlottesville.
Amy KilleleaAt the time of this study, Karishma Srikanth was with the Batten School of Leadership and Public Policy, University of Virginia, Charlottesville. Edwin Corbin Gutierrez and Tim Horn were with the National Alliance of State & Territorial AIDS Directors (NASTAD), Washington, DC. Amy Killelea was with NASTAD and Killelea Consulting, Arlington, Virginia. Andrew Strumpf and Kathleen A. McManus are with the Division of Infectious Diseases and International Health, University of Virginia, Charlottesville.
Andrew StrumpfAt the time of this study, Karishma Srikanth was with the Batten School of Leadership and Public Policy, University of Virginia, Charlottesville. Edwin Corbin Gutierrez and Tim Horn were with the National Alliance of State & Territorial AIDS Directors (NASTAD), Washington, DC. Amy Killelea was with NASTAD and Killelea Consulting, Arlington, Virginia. Andrew Strumpf and Kathleen A. McManus are with the Division of Infectious Diseases and International Health, University of Virginia, Charlottesville.
Edwin Corbin-GutierrezAt the time of this study, Karishma Srikanth was with the Batten School of Leadership and Public Policy, University of Virginia, Charlottesville. Edwin Corbin Gutierrez and Tim Horn were with the National Alliance of State & Territorial AIDS Directors (NASTAD), Washington, DC. Amy Killelea was with NASTAD and Killelea Consulting, Arlington, Virginia. Andrew Strumpf and Kathleen A. McManus are with the Division of Infectious Diseases and International Health, University of Virginia, Charlottesville.
Tim HornAt the time of this study, Karishma Srikanth was with the Batten School of Leadership and Public Policy, University of Virginia, Charlottesville. Edwin Corbin Gutierrez and Tim Horn were with the National Alliance of State & Territorial AIDS Directors (NASTAD), Washington, DC. Amy Killelea was with NASTAD and Killelea Consulting, Arlington, Virginia. Andrew Strumpf and Kathleen A. McManus are with the Division of Infectious Diseases and International Health, University of Virginia, Charlottesville.
Kathleen A McManusAt the time of this study, Karishma Srikanth was with the Batten School of Leadership and Public Policy, University of Virginia, Charlottesville. Edwin Corbin Gutierrez and Tim Horn were with the National Alliance of State & Territorial AIDS Directors (NASTAD), Washington, DC. Amy Killelea was with NASTAD and Killelea Consulting, Arlington, Virginia. Andrew Strumpf and Kathleen A. McManus are with the Division of Infectious Diseases and International Health, University of Virginia, Charlottesville.
Funding
Deconstructing HIV Disparities: Multistate Study of Data, Outcomes and MediatorsK08AI136644 · NIAID · UNIVERSITY OF VIRGINIA · PI MCMANUS, KATHLEEN ANN · 2018 to 2022
$1.0MNIAID NIH HHS K08 AI136644
Abstract
PubMed holds no abstract for this paper.
Indexed as
Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisHumansUnited StatesAnti-HIV Agents
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.